APA

Clendenning M., Macrae F. A., Walsh M. D., Walters R. J., Thibodeau S. N., Gunawardena S. R., Potter J. D., Haile R. W., Gallinger S., Hopper J. L., Jenkins M. A., Rosty C., Young J. P. & Buchanan D. D. (20131204). Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression. : Clinical genetics.

Chicago

Clendenning M, Macrae F A, Walsh M D, Walters R J, Thibodeau S N, Gunawardena S R, Potter J D, Haile R W, Gallinger S, Hopper J L, Jenkins M A, Rosty C, Young J P and Buchanan D D. 20131204. Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression. : Clinical genetics.

Harvard

Clendenning M., Macrae F. A., Walsh M. D., Walters R. J., Thibodeau S. N., Gunawardena S. R., Potter J. D., Haile R. W., Gallinger S., Hopper J. L., Jenkins M. A., Rosty C., Young J. P. and Buchanan D. D. (20131204). Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression. : Clinical genetics.

MLA

Clendenning M, Macrae F A, Walsh M D, Walters R J, Thibodeau S N, Gunawardena S R, Potter J D, Haile R W, Gallinger S, Hopper J L, Jenkins M A, Rosty C, Young J P and Buchanan D D. Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression. : Clinical genetics. 20131204.